InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-16.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Crowe Suzanne, Director. Insider active across 1 company, notably AVITA Medical, Inc.. Aggregated, 9 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €37k. Activity tracked since 20 September 2021. The latest transaction was filed on 9 December 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
22,214 sharesCommon StockSEC:0001816242-26-000002:0
486 shares@ US$13.1516.3% of flowCommon StockSEC:0000950170-25-010560:0
Ideal exit: 5 Sept 2025 (T+270)
9,200 sharesCommon StockSEC:0000950170-24-070118:0
6,175 sharesCommon StockSEC:0001209191-23-035434:0
12,589 sharesCommon StockSEC:0001209191-22-061281:0
4,350 sharesCommon StockSEC:0001209191-21-071257
4,350 sharesCommon StockSEC:0001209191-21-071257:0
1,066 shares@ US$17.0841.8% of flowCommon StockSEC:0001209191-21-057037
Ideal exit: 17 Jun 2022 (T+270)
1,066 shares@ US$17.080.015% mcap50.0% of flowCommon StockSEC:0001209191-21-057037:0
Ideal exit: 17 Jun 2022 (T+270)
9 of 9 declarations
About Crowe Suzanne
Suzanne Crowe is a Director at AVITA Medical, Inc. In this role, she participates in the governance of the company and in strategic decision-making. Her experience and management skills are essential in guiding AVITA in its growth and innovation initiatives.
